Inflammation in atherosclerosis: Drivers, mechanisms and therapies
Acta Pharmaceutica Sinica B · 2026-08 · 16 (8) · 4770-4807
DOI: 10.1016/j.apsb.2026.06.047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-08. Verfasst von Zihan Su und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Divi…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 484 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technolo…
- Anhui Provincial Key Laboratory of Metabolic Health and Panvascular Diseases, Hefei 230001, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Su, Z., & Xu, S. (2026). Inflammation in atherosclerosis: Drivers, mechanisms and therapies. Acta Pharmaceutica Sinica B, 16(8), 4770-4807. https://doi.org/10.1016/j.apsb.2026.06.047
Vancouver
Su Z, Xu S. Inflammation in atherosclerosis: Drivers, mechanisms and therapies. Acta Pharmaceutica Sinica B. 2026;16(8):4770-4807. doi:10.1016/j.apsb.2026.06.047
BibTeX
@article{Su2026,
author = {Su, Zihan and Xu, Suowen},
title = {Inflammation in atherosclerosis: Drivers, mechanisms and therapies},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {8},
pages = {4770--4807},
doi = {10.1016/j.apsb.2026.06.047}
}
EUVIMED